{"id":"new-formulation-etanercept","safety":{"commonSideEffects":[{"rate":"30%","effect":"Infections (e.g., upper respiratory infections, sinusitis)"},{"rate":"15%","effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1201572","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Etanercept binds to TNF-α, preventing it from interacting with its receptors on the surface of cells, thereby inhibiting the inflammatory response that contributes to various autoimmune diseases.","oneSentence":"New Formulation Etanercept blocks the action of tumor necrosis factor-alpha (TNF-α), reducing inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:21.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Psoriatic arthritis"},{"name":"Ankylosing spondylitis"},{"name":"Plaque psoriasis"}]},"trialDetails":[{"nctId":"NCT02986139","phase":"PHASE3","title":"Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis","status":"COMPLETED","sponsor":"Amgen","startDate":"2016-11-29","conditions":"Arthritis, Rheumatoid; Arthritis, Psoriatic","enrollment":111}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"New Formulation Etanercept","genericName":"New Formulation Etanercept","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"New Formulation Etanercept blocks the action of tumor necrosis factor-alpha (TNF-α), reducing inflammation. Used for Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}